Companies: 48,686 Total Market Cap: 126722197829037.30

PolyNovo Limited

ASX-PNV
Healthcare Medical Devices
Rank #12797
Market Cap 537.71 M
Volume 183,342.17
Price 0.79
Change (%) 1.25%
Country or region Australia Australia

PolyNovo Limited's latest marketcap:

537.71 M

As of May 7, 2025, PolyNovo Limited's market capitalization has reached $537.71 M. According to our data, PolyNovo Limited is the 12797th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 537.71 M
Revenue (ttm) 74.97 M
Net Income (ttm) 3.83 M
Shares Out 690.84 M
EPS (ttm) 0.01
Forward PE 80.54
Ex-Dividend Date n/a
Earnings Date May 23, 2025
Market Cap Chart
Data Updated: May 7, 2025

PolyNovo Limited's yearly market capitalization.

PolyNovo Limited has seen its market value drop from A$2.57 B to A$829.01 M since 2020, representing a total decrease of 67.68% and an annual compound decline rate (CAGR) of 22.88%.
Date Market Cap Change (%)
May 7, 2025 A$829.01 M -37.25%
December 31, 2024 A$1.41 B 23.37%
December 29, 2023 A$1.14 B -17.8%
December 30, 2022 A$1.39 B 37.79%
December 31, 2021 A$1.01 B -60.68%
December 31, 2020 A$2.57 B

Company Profile

About PolyNovo Limited

PolyNovo Limited specializes in the design, manufacture, and sale of biodegradable medical devices, serving markets in the United States, Australia, New Zealand, and internationally.

Key Products

  • NovoSorb Biodegradable Temporising Matrix: A dermal scaffold used for dermis regeneration following extensive surgery, trauma, or burns.
  • Hernia Repair Solutions: Developing devices for ventral hernia and complex abdominal wall reconstruction.
  • NovoSorb Dermal Beta Cell: An innovative intracutaneous ectopic pancreas treatment for type 1 diabetes.
  • NovoSorb MTX: Designed for single-stage grafting in burns, chronic wounds, and surgical wounds.
  • Plastics & Reconstructive Devices: A range of products for reconstructive surgery.

Company Background

Originally named Calzada Limited, the company rebranded as PolyNovo Limited in November 2014. Founded in 1998, PolyNovo is headquartered in Port Melbourne, Australia.

Frequently Asked Questions

As of May 7, 2025, PolyNovo Limited (including the parent company, if applicable) has an estimated market capitalization of $537.71 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

PolyNovo Limited global market capitalization ranking is approximately 12797 as of May 7, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Australia
Founded 1998
IPO Date n/a
Employees 254
CEO Robyn Elliott
Sector Healthcare
Industry Medical Devices
Address 320 Lorimer Street
Port Melbourne, 3207
Australia